AFT Pharmaceuticals
(ASX:AFP) has confirmed that it’s having some supply issues with international manufacturer, PHARMAC.
There is currently a shortage of the heart medication, Metoprolol, in NZ. The company says that one of the reasons for the supply shortage in NZ is because there is a global shortage.
AFT’s managing director, Dr Hartley Atkinson, says this is a manufacturing issue they could not have foreseen.
Dr Atkinson also says this issue is likely to affect the company’s 2017 FY revenues, but isn’t able to quantify the impact yet.
AFT reported a net loss of $11.95 million at 31 March 2016.
